Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients

In cases of COVID-19 acute respiratory distress syndrome, an excessive host inflammatory response has been reported, with elevated serum interleukin-6 levels. In this multicenter retrospective cohort study we included adult patients with COVID-19, need of respiratory support, and elevated C-reactive...

Descripción completa

Detalles Bibliográficos
Autores principales: Canziani, Lorenzo M., Trovati, Serena, Brunetta, Enrico, Testa, Amidio, De Santis, Maria, Bombardieri, Emilio, Guidelli, Giacomo, Albano, Giovanni, Folci, Marco, Squadroni, Michela, Beretta, Giordano D., Ciccarelli, Michele, Castoldi, Massimo, Lleo, Ana, Aghemo, Alessio, Vernile, Laura, Malesci, Alberto, Omodei, Paolo, Angelini, Claudio, Badalamenti, Salvatore, Cecconi, Maurizio, Cremonesi, Alberto, Selmi, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342030/
https://www.ncbi.nlm.nih.gov/pubmed/32713677
http://dx.doi.org/10.1016/j.jaut.2020.102511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342030/
https://www.ncbi.nlm.nih.gov/pubmed/32713677
http://dx.doi.org/10.1016/j.jaut.2020.102511

Ejemplares similares